DrugPatentWatch Database Preview
ZURAMPIC Drug Profile
Which patents cover Zurampic, and what generic alternatives are available?
Zurampic is a drug marketed by Ironwood Pharms Inc and is included in one NDA. There are eight patents protecting this drug.
This drug has one hundred and seventy-five patent family members in thirty-eight countries.
The generic ingredient in ZURAMPIC is lesinurad. Two suppliers are listed for this compound. Additional details are available on the lesinurad profile page.
Summary for ZURAMPIC
| International Patents: | 175 |
| US Patents: | 8 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 53 |
| Patent Applications: | 52 |
| Drug Prices: | Drug price information for ZURAMPIC |
| DailyMed Link: | ZURAMPIC at DailyMed |
Generic Entry Opportunity Date for ZURAMPIC
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for ZURAMPIC
| Drug Class | Urate Transporter 1 Inhibitor |
| Mechanism of Action | Urate Transporter 1 Inhibitors Cytochrome P450 3A Inducers |
Synonyms for ZURAMPIC
| (5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid |
| {[5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-1,2,4-TRIAZOL-3-YL]SULFANYL}ACETIC ACID |
| {[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid |
| 09ERP08I3W |
| 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid |
| 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid |
| 2-(5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid |
| 2-[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic acid |
| 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid |
| 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid |
| 2-{[5-broMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid |
| 3777AH |
| 878672-00-5 |
| Acetic acid, 2-((5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)- |
| Acetic acid,[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]- |
| ACN-050764 |
| AK323774 |
| AKOS027327368 |
| C17H14BrN3O2S |
| CHEBI:90929 |
| CHEMBL2105720 |
| CS-1389 |
| D09921 |
| D0C3SW |
| DB11560 |
| EX-A1289 |
| FGQFOYHRJSUHMR-UHFFFAOYSA-N |
| GTPL7673 |
| HE067018 |
| HY-15258 |
| KB-78121 |
| KS-00000LAE |
| LESINURAD |
| Lesinurad (RDEA-594) |
| Lesinurad (RDEA594 pound(c) |
| Lesinurad (RDEA594) |
| Lesinurad (USAN) |
| Lesinurad [USAN:INN] |
| Lesinurad, >=98% (HPLC) |
| MFCD22572730 |
| MolPort-039-138-666 |
| RDEA 594 |
| RDEA-594 |
| RDEA594 |
| s4640 |
| SC-94287 |
| SCHEMBL842962 |
| UNII-09ERP08I3W |
| W-5949 |
| ZINC84757007 |
| Zurampic (TN) |
US Patents and Regulatory Information for ZURAMPIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for ZURAMPIC
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 101817793 | ➤ Sign Up |
| Croatia | P20140950 | ➤ Sign Up |
| Singapore | 190902 | ➤ Sign Up |
| South Africa | 201203779 | ➤ Sign Up |
| Slovenia | 2658846 | ➤ Sign Up |
| Lithuania | PA2016024 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for ZURAMPIC
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| /2016 | Austria | ➤ Sign Up | PRODUCT NAME: LESINURAD ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1080 (MITTEILUNG) 20160222 |
| 2016000060 | Germany | ➤ Sign Up | PRODUCT NAME: LESINURAD ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1080 20160218 |
| 2016 00034 | Denmark | ➤ Sign Up | PRODUCT NAME: LESINURAD ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU1/15/1080 20160222 |
| 169 | Luxembourg | ➤ Sign Up | PRODUCT NAME: LESINURAD , OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION DATE: 20160222 |
| 2016 00034 | Denmark | ➤ Sign Up | PRODUCT NAME: LESINURAD ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU1/15/1080 20160222 |
| C0031 | France | ➤ Sign Up | PRODUCT NAME: LESINURAD; REGISTRATION NO/DATE: EU/1/15/1080 20160222 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
